相关实验视频
Updated: Jun 7, 2025

03:22
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
609
在COVID-19患者中膜溢出的预后相关性 - 一项德国多中心研究
Andreas Michael Bucher1, Julia Dietz1, Constantin Ehrengut2
1Department of Diagnostic and Interventional Radiology, Goethe University Hospital Frankfurt, 60590, Frankfurt Am Main, Germany.
Clinical imaging
|November 12, 2024
概括
在COVID-19患者中,胸腔溢液 (PE) 显著预测了更高的30天死亡率. 识别PE,无论其特征如何,对于评估预后和指导患者护理至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 放射学 放射学是指放射学
背景情况:
- 由于COVID-19的流行,导致了显著的死亡率和发病率.
- 流 (PE) 是肺炎的常见发现,但其在COVID-19中的预后作用需要澄清.
研究的目的:
- 评估COVID-19患者中膜溢出 (PE) 的预后意义.
- 确定PE是否预测临床结果,例如30天死亡率,ICU入院和机械通风需求.
主要方法:
- 从RACOON项目中对1183名COVID-19患者进行了回顾性分析.
- 胸部CT扫描被用来评估PE的存在.
- 研究了PE与30天死亡率,ICU入院和机械通风的关联.
主要成果:
- 在31.5%的COVID-19患者中检测到腹腔溢出 (PE).
- 长期发育与30天死亡率的增加显著相关 (HR 2.22,p < 0.001).
- 在PE体积/密度和死亡率之间没有发现显著的相关性.
结论:
- 流是COVID-19患者30天死亡率增加的独立预测因素.
- 无论体积或密度如何,识别PE对于预后评估至关重要.
- 对PE的放射性报告可以帮助临床决策对COVID-19管理.
相关概念视频
Pleural Effusion II: Symptoms and Management
154
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
154
Pleural Effusion I: Introduction
602
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
602
Pneumonia III: Complications and Assessment
170
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
170
Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
Pneumonia II: Pathophysiology
217
The pathophysiology of pneumonia involves the following steps:
217
Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299

